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Drs. Agosti and Goldie Reply: As we noted, the need for long-term follow-up data are important, which Suba and Raab emphasize. Furthermore, it is imperative that momentum behind efforts in the past decade to develop feasible options for cervicalcancer screening in low-resource settings continues to build. The Bill and Melinda Gates Foundation provided $55.6 million to the Alliance for Cervical Cancer Prevention to promote screening and $13 million toward the development of lowcost HPV DNA tests and other tests. We believe it is inequitable to exclude women in developing 1.
2.
countries from the potential benefits of vaccination, new technology, and screening approaches that appear to be promising. 1 We emphasized that an integrated approach that includes screening and vaccination is likely to prevent the greatest number of deaths from cervical cancer. However, countries will make their own decisions about the best strategic approach to cervical-cancer prevention, accounting for local epidemiologic factors and disease burden, 2 competing priorities, and the cost-effectiveness, affordability, and feasibility of vaccination programs targeting adolescents and the screening of adult women. We urge that attention be given to realworld solutions for preventing death from cervical cancer in women living in poverty. 

Human Papillomavirus and Oropharyngeal Cancer
To the Editor: The study by D'Souza et al. (May 10 issue) 1 on oropharyngeal squamous-cell carcinomas associated with human papillomavirus (HPV) provides important epidemiologic insights into a cancer that is becoming increasingly common in the United States. 2 However, the molecular mechanisms of carcinogenesis in HPV-associated oropharyngeal squamous-cell carcinomas remain unclear.
The integration of HPV type 16 (HPV-16) into the host genome is an important mechanism in cervical carcinogenesis, 3 but there is no direct evidence that this process occurs in oropharyngeal squamous-cell carcinomas. The authors state that Southern blot, real-time polymerase-chain-reaction (PCR), and fluorescence in situ hybridization analyses 4 have established integration sites but that these methods provide only indirect evidence. Direct evidence would require observation of the viral DNA sequence either flanked or attached to one end of human DNA (junction sequences). Mellin et al. 5 did not observe this finding in HPV-16-positive tonsillar carcinomas. We previously used restriction-site PCR in more than 100 HPV-16 and HPV-18 cervical cancers to identify many of these junction sequences. 6 However, when we used this same technique in 40 oropharyngeal squamouscell carcinomas that were positive for HPV-16, we did not detect junction sequences (unpublished data). This finding, which suggests a mechanism of carcinogenesis that is distinct from that in cervical cancer, warrants further investigation. 
To the Editor:
Little is known about the natural history of oral HPV infection. 1 In a cohort of 360 healthy students (mean age, 18.7 years), 69% of whom were female, 2 we tested oral cytobrush samples for HPV DNA by means of multiplex PCR. Of these students, 20 (5.6%) were positive for HPV. Three years later, 8 of 183 students who were retested (4.4%) were positive, and 1 had persistent infection. Oral HPV infection was unusual, and the persistence of infection was rare.
Of the 183 students who were retested, 28 were sexually inactive, and all these students were HPVnegative. Of the sexually active students, 100% of those who were HPV-positive had had both penetrative and oral-genital sex in the previous 3 years; of those sexually active students who were HPVnegative, 88% had had only penetrative sex and 86% had had only oral-genital sex. These findings support the hypothesis that oral HPV is transmitted through sexual contact and that oral-genital contact is the likely mechanism. Hilary Williams, M.B., Ch.B., Ph.D. 
4.
5.
6.
1.
2.
squamous-cell carcinomas. This finding is unlikely to be related to the detection method, 1 since in situ hybridization was used, a reliable technique with a test outcome that is often similar to that of viral oncogene transcript analysis. 2 We previously reported that in a Dutch cohort, 6 of 37 oropharyngeal carcinomas (16%) contained transcriptionally active HPV. 3 This prevalence differs significantly (P<0.001) from that reported by D'Souza et al. A review article also reported a prevalence of HPV in oropharyngeal carcinomas that was much lower than 72%. 4 We wonder whether the associations reported by DeSouza et al. can be extrapolated to other populations.
